mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
2e-08 |
mRNA |
linifanib |
CTRPv2 |
pan-cancer |
AAC |
0.28 |
3e-08 |
mRNA |
BRD-A02303741:navitoclax (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
3e-08 |
mRNA |
quizartinib |
CTRPv2 |
pan-cancer |
AAC |
0.29 |
3e-08 |
mRNA |
AZD7762 |
CTRPv2 |
pan-cancer |
AAC |
0.25 |
4e-08 |
mRNA |
alisertib |
CTRPv2 |
pan-cancer |
AAC |
0.24 |
5e-08 |
mRNA |
TG-101348 |
GDSC1000 |
pan-cancer |
AAC |
0.28 |
6e-08 |
mRNA |
carboplatin:etoposide (40:17 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.22 |
1e-07 |
mRNA |
tivozanib |
CTRPv2 |
pan-cancer |
AAC |
0.27 |
1e-07 |
mRNA |
ABT-199 |
CTRPv2 |
pan-cancer |
AAC |
0.32 |
1e-07 |